Ftse Mib
34.490,71
0,07%
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
NASDAQ
16.920,79
1,10%
Bitcoin
68.623,72
0,14%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Talis Biomedical Corporation (TLIS) Talis Biomedical Corporation (TLIS) Notizie

TLIS

Talis Biomedical (TLIS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TLIS
DataOraFonteTitoloSimboloCompagnia
08/05/202414:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TLISTalis Biomedical Corporation
26/01/202422:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
14/11/202314:00GlobeNewswire Inc.Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve CashNASDAQ:TLISTalis Biomedical Corporation
10/08/202323:01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TLISTalis Biomedical Corporation
10/08/202322:05GlobeNewswire Inc.Talis Biomedical Announces Second Quarter 2023 Financial Results and Business UpdateNASDAQ:TLISTalis Biomedical Corporation
03/08/202314:00GlobeNewswire Inc.Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023NASDAQ:TLISTalis Biomedical Corporation
02/08/202314:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
02/08/202314:17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
02/08/202314:00GlobeNewswire Inc.Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)NASDAQ:TLISTalis Biomedical Corporation
27/07/202314:00GlobeNewswire Inc.New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedical’s Women’s and Sexual Health Product MenuNASDAQ:TLISTalis Biomedical Corporation
24/07/202314:00GlobeNewswire Inc.Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:TLISTalis Biomedical Corporation
05/07/202314:00GlobeNewswire Inc.Talis Biomedical Announces 1-for-15 Reverse Stock SplitNASDAQ:TLISTalis Biomedical Corporation
13/06/202322:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
09/06/202322:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TLISTalis Biomedical Corporation
23/05/202314:00GlobeNewswire Inc.Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent DirectorNASDAQ:TLISTalis Biomedical Corporation
11/05/202322:05GlobeNewswire Inc.Talis Biomedical Announces Business Update and First Quarter 2023 Financial ResultsNASDAQ:TLISTalis Biomedical Corporation
04/05/202314:00GlobeNewswire Inc.Talis Biomedical to Provide Business Update and Financial Results on May 11, 2023NASDAQ:TLISTalis Biomedical Corporation
28/04/202322:20Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TLISTalis Biomedical Corporation
28/04/202322:15Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TLISTalis Biomedical Corporation
22/03/202321:05GlobeNewswire Inc.Talis Announces Fourth Quarter and Full Year 2022 Financial ResultsNASDAQ:TLISTalis Biomedical Corporation
10/03/202322:56Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TLISTalis Biomedical Corporation
10/03/202322:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TLISTalis Biomedical Corporation
15/02/202312:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TLISTalis Biomedical Corporation
16/11/202208:57TipRanksTalis Biomedical (TLIS) Gets a Sell from BTIGNASDAQ:TLISTalis Biomedical Corporation
03/11/202221:05GlobeNewswire Inc.Talis Biomedical Reports Third Quarter 2022 Financial ResultsNASDAQ:TLISTalis Biomedical Corporation
02/08/202222:05GlobeNewswire Inc.Talis Biomedical Provides Business Update and Reports Second Quarter Financial ResultsNASDAQ:TLISTalis Biomedical Corporation
24/05/202222:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:TLISTalis Biomedical Corporation
12/05/202209:45TipRanksBTIG Sticks to Its Sell Rating for Talis Biomedical (TLIS)NASDAQ:TLISTalis Biomedical Corporation
10/05/202222:05GlobeNewswire Inc.Talis Biomedical Announces First Quarter 2022 Financial ResultsNASDAQ:TLISTalis Biomedical Corporation
26/04/202214:00GlobeNewswire Inc.Talis Biomedical to Announce First Quarter 2022 Financial Results on May 10, 2022NASDAQ:TLISTalis Biomedical Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TLIS

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
TIT
Telecom Italia
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TEN
Tenaris
BIT
RACE
Ferrari NV
BIT
SPM
Saipem
BIT
BAMI
Banco BPM
BIT
PRY
Prysmian
BIT
BPE
Bper Banca
BIT
TITR
Telecom Italia
BIT
SRG
Snam
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network